Download MendeleyA human antibody against Zika virus crosslinks the E protein to prevent infection.
Hasan, S.S., Miller, A., Sapparapu, G., Fernandez, E., Klose, T., Long, F., Fokine, A., Porta, J.C., Jiang, W., Diamond, M.S., Crowe, J.E., Kuhn, R.J., Rossmann, M.G.(2017) Nat Commun 8: 14722-14722
- PubMed: 28300075
- DOI: https://doi.org/10.1038/ncomms14722
- Primary Citation of Related Structures:
5UHY - PubMed Abstract:
The recent Zika virus (ZIKV) epidemic has been linked to unusual and severe clinical manifestations including microcephaly in fetuses of infected pregnant women and Guillian-Barré syndrome in adults. Neutralizing antibodies present a possible therapeutic approach to prevent and control ZIKV infection. Here we present a 6.2 Å resolution three-dimensional cryo-electron microscopy (cryoEM) structure of an infectious ZIKV (strain H/PF/2013, French Polynesia) in complex with the Fab fragment of a highly therapeutic and neutralizing human monoclonal antibody, ZIKV-117. The antibody had been shown to prevent fetal infection and demise in mice. The structure shows that ZIKV-117 Fabs cross-link the monomers within the surface E glycoprotein dimers as well as between neighbouring dimers, thus preventing the reorganization of E protein monomers into fusogenic trimers in the acidic environment of endosomes.
Organizational Affiliation:
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907, USA.
